Walnut, CA, United States of America

Hyunok Lynn Kim


Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 733(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Hyunok Lynn Kim

Introduction

Hyunok Lynn Kim is a notable inventor based in Walnut, CA, who has made significant contributions to the field of medical devices. With a total of 4 patents to her name, she has focused on enhancing skin penetration techniques through innovative devices.

Latest Patents

One of her latest patents is a "Device and method for enhancing skin piercing by microprotrusions." This invention involves pre-stretching the skin to improve pathway formation when microprotrusions are pressed into the skin. The device features skin-engaging opposite ends that contact the skin surface, allowing for skin stretching when expanded. The skin is placed under a tension of about 0.01 to 10 megapascals, with a preference for 0.05 to 2 megapascals. The device includes multiple microprotrusions that penetrate the skin while it is being stretched. Another notable invention is a "Device for enhancing transdermal agent flux," which comprises a sheet member with microprotrusions for skin penetration and a rigid support that evenly transmits applied force across the sheet member.

Career Highlights

Hyunok Lynn Kim is currently associated with Alza Corporation, where she continues to develop innovative medical technologies. Her work has been instrumental in advancing methods for drug delivery and skin treatment.

Collaborations

She has collaborated with notable colleagues, including Joseph Creagan Trautman and Michael G. Zuck, contributing to the advancement of their shared goals in medical innovation.

Conclusion

Hyunok Lynn Kim's contributions to the field of medical devices, particularly in enhancing skin penetration techniques, highlight her innovative spirit and dedication to improving healthcare solutions. Her work continues to pave the way for advancements in transdermal drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…